Stephan Bernhardt

673 total citations
22 papers, 498 citations indexed

About

Stephan Bernhardt is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Stephan Bernhardt has authored 22 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Stephan Bernhardt's work include Renal cell carcinoma treatment (4 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Epigenetics and DNA Methylation (4 papers). Stephan Bernhardt is often cited by papers focused on Renal cell carcinoma treatment (4 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Epigenetics and DNA Methylation (4 papers). Stephan Bernhardt collaborates with scholars based in Germany, United States and United Kingdom. Stephan Bernhardt's co-authors include Trond Buanes, Jon Amund Eriksen, Mona Møller, Gustav Gaudernack, Dagmar S. Trachsel, Ulrike Korf, Stefan Wiemann, Tim Beißbarth, Astrid Wachter and Martina Vetter and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Stephan Bernhardt

21 papers receiving 488 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephan Bernhardt Germany 10 277 208 157 120 53 22 498
Yin Gu United States 13 211 0.8× 137 0.7× 164 1.0× 95 0.8× 22 0.4× 23 491
Guo‐Liang Shen China 12 206 0.7× 149 0.7× 135 0.9× 89 0.7× 43 0.8× 48 464
Ori Hassin Israel 6 307 1.1× 264 1.3× 65 0.4× 136 1.1× 44 0.8× 8 522
Carla Azzurra Amoreo Italy 15 249 0.9× 193 0.9× 45 0.3× 148 1.2× 23 0.4× 25 492
Ruizhao Qi China 11 222 0.8× 325 1.6× 220 1.4× 128 1.1× 24 0.5× 20 706
Siti‐Faujiah Hendrayani Saudi Arabia 8 267 1.0× 339 1.6× 128 0.8× 89 0.7× 17 0.3× 8 532
Maria Teresa Bilotta Italy 8 200 0.7× 142 0.7× 189 1.2× 80 0.7× 15 0.3× 12 465
Zhengkai Liao China 13 235 0.8× 117 0.6× 79 0.5× 72 0.6× 63 1.2× 31 429
Xiaofang Zhao China 11 192 0.7× 216 1.0× 105 0.7× 139 1.2× 19 0.4× 27 551
Junfang Ji China 8 362 1.3× 107 0.5× 79 0.5× 113 0.9× 18 0.3× 11 478

Countries citing papers authored by Stephan Bernhardt

Since Specialization
Citations

This map shows the geographic impact of Stephan Bernhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephan Bernhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephan Bernhardt more than expected).

Fields of papers citing papers by Stephan Bernhardt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephan Bernhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephan Bernhardt. The network helps show where Stephan Bernhardt may publish in the future.

Co-authorship network of co-authors of Stephan Bernhardt

This figure shows the co-authorship network connecting the top 25 collaborators of Stephan Bernhardt. A scholar is included among the top collaborators of Stephan Bernhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephan Bernhardt. Stephan Bernhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kinch, Lisa N., Stephan Bernhardt, Beth Levine, et al.. (2024). GRB2 is a BECN1 interacting protein that regulates autophagy. Cell Death and Disease. 15(1). 14–14. 5 indexed citations
2.
Berdiel‐Acer, Mireia, Eileen Reinz, Johanna Sonntag, et al.. (2022). Disentangling ERBB Signaling in Breast Cancer Subtypes—A Model-Based Analysis. Cancers. 14(10). 2379–2379. 3 indexed citations
3.
Strauß, Arne, Marianne Schmid, Michael Rink, et al.. (2021). Real-World Outcomes in Patients with Metastatic Renal Cell Carcinoma According to Risk Factors: The STAR-TOR Registry. Future Oncology. 17(18). 2325–2338. 5 indexed citations
4.
Byron, Adam, Stephan Bernhardt, Bérengère Ouine, et al.. (2020). Integrative analysis of multi-platform reverse-phase protein array data for the pharmacodynamic assessment of response to targeted therapies. Scientific Reports. 10(1). 21985–21985. 11 indexed citations
5.
Boegemann, Martin, Katrin Schlack, Michael Rink, et al.. (2020). Effect of Comorbidities/Comedications on Sunitinib Outcomes for Metastatic Renal Cell Carcinoma: the STAR-TOR Registry. Future Oncology. 16(35). 2939–2948. 11 indexed citations
6.
Moran, Michael, Michael Rink, Lothar Bergmann, et al.. (2020). Real-world outcomes in patients with metastatic renal cell carcinoma according to risk factors: Analysis of the STAR TOR registry.. Journal of Clinical Oncology. 38(6_suppl). 628–628.
7.
Bernhardt, Stephan, Michael Rink, Lothar Bergmann, et al.. (2020). Effect of comorbidities/comedications on treatment outcomes with sunitinib in patients (pts) with metastatic renal cell carcinoma (mRCC): Subgroup analyses from the STAR-TOR registry.. Journal of Clinical Oncology. 38(6_suppl). 631–631. 1 indexed citations
8.
Vega-Rubín-de-Celis, Silvia, Stephan Bernhardt, Heike Wilhelm, et al.. (2020). Abrogating GPT2 in triple‐negative breast cancer inhibits tumor growth and promotes autophagy. International Journal of Cancer. 148(8). 1993–2009. 21 indexed citations
9.
Bernhardt, Stephan, Christian Tönsing, Karin Müller‐Decker, et al.. (2019). Functional Proteomics of Breast Cancer Metabolism Identifies GLUL as Responder during Hypoxic Adaptation. Journal of Proteome Research. 18(3). 1352–1362. 7 indexed citations
10.
Breunig, Christian, Alexander Bott, Eileen Reinz, et al.. (2018). TGFβ1 regulates HGF‐induced cell migration and hepatocyte growth factor receptor MET expression via C‐ets‐1 and miR‐128‐3p in basal‐like breast cancer. Molecular Oncology. 12(9). 1447–1463. 25 indexed citations
11.
Bernhardt, Stephan, Michaela Bayerlová, Martina Vetter, et al.. (2017). Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors. Breast Cancer Research. 19(1). 112–112. 80 indexed citations
12.
Leszczyńska, Katarzyna B., Deborah Biasoli, Monica M. Olcina, et al.. (2016). Mechanisms and consequences of ATMIN repression in hypoxic conditions: roles for p53 and HIF-1. Scientific Reports. 6(1). 21698–21698. 15 indexed citations
13.
Wachter, Astrid, Stephan Bernhardt, Tim Beißbarth, & Ulrike Korf. (2015). Analysis of Reverse Phase Protein Array Data: From Experimental Design towards Targeted Biomarker Discovery. SHILAP Revista de lepidopterología. 4(4). 520–539. 11 indexed citations
14.
Sonntag, Johanna, Kerstin Schlüter, Stephan Bernhardt, & Ulrike Korf. (2014). Subtyping of breast cancer using reverse phase protein arrays. Expert Review of Proteomics. 11(6). 757–770. 13 indexed citations
15.
Bernhardt, Stephan, Zita Soons, Gernot Poschet, et al.. (2014). Metabolic transformations in breast cancer subtypes. Cancer & Metabolism. 2(S1). 3 indexed citations
16.
Bache, Matthias, Stephan Bernhardt, Henri Wichmann, et al.. (2014). Betulinic Acid Derivatives NVX-207 and B10 for Treatment of Glioblastoma—An in Vitro Study of Cytotoxicity and Radiosensitization. International Journal of Molecular Sciences. 15(11). 19777–19790. 32 indexed citations
17.
Stauber, R.E., Thomas Scherzer, Csilla Putz‐Bankuti, et al.. (2011). 1186 BASELINE VITAMIN D LEVELS DO NOT INFLUENCE SVR IN PATIENTS WITH CHRONIC HCV GENOTYPE 1 OR 4 INFECTION UNDERGOING PEGINTERFERON/RIBAVIRIN TREATMENT. Journal of Hepatology. 54. S468–S469. 5 indexed citations
18.
Buanes, Trond, et al.. (2008). Immunotherapy of patients with pancreatic adenocarcinoma: Influence of adjuvants. Journal of Clinical Oncology. 26(15_suppl). 15542–15542. 2 indexed citations
19.
Bernhardt, Stephan, Dagmar S. Trachsel, Mona Møller, et al.. (2006). Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: a dose escalating phase I/II study. British Journal of Cancer. 95(11). 1474–1482. 238 indexed citations
20.
Bernhardt, Stephan, et al.. (2005). Imiquimod a new adjuvant for telomerase peptide vaccine: A phase I trial in patients with inoperable pancreatic cancer. Journal of Clinical Oncology. 23(16_suppl). 9623–9623. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yin Gu Breakdown of academic impact, for papers by Guo‐Liang Shen Breakdown of academic impact, for papers by Ori Hassin Breakdown of academic impact, for papers by Carla Azzurra Amoreo Breakdown of academic impact, for papers by Ruizhao Qi Breakdown of academic impact, for papers by Siti‐Faujiah Hendrayani Breakdown of academic impact, for papers by Maria Teresa Bilotta Breakdown of academic impact, for papers by Zhengkai Liao Breakdown of academic impact, for papers by Xiaofang Zhao Breakdown of academic impact, for papers by Junfang Ji
Rankless by CCL
2026